Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Direct costs attributable to producing goods sold
5Y CAGR
-64.7%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $44000.00 | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | - |
| 2022 | $0.00 | -100.0% |
| 2021 | $12.30M | +53.9% |
| 2020 | $8.00M | -6.8% |
| 2019 | $8.58M | - |